DETAILS, FICTION AND MBL77

For people with symptomatic condition necessitating therapy, ibrutinib is frequently recommended based on four stage III randomized clinical trials comparing ibrutinib with chlorambucil monotherapy106 along with other commonly applied CIT mixtures, namely FCR, bendamustine furthermore rituximab and chlorambucil plus obinutuzumab (ClbO).107–109 Ib